Clinical trial
PET Imaging of Phosphodiesterase-4 (PDE4) in Brain and Peripheral Organs of Mccune-Albright Syndrome
NCT02743377 is registered in ClinicalTrials.gov with National Institute of Mental Health (NIMH) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PET Imaging of Phosphodiesterase-4 (PDE4) in Brain and Peripheral Organs of Mccune-Albright Syndrome
- Lead sponsor
- National Institute of Mental Health (NIMH)
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- April 4, 2018
- Completion date
- May 19, 2020
- Enrollment
- 16 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
nervous system disease